文献速递外周动脉疾病

血管内碎石术在孤立性腘动脉病变中的应用及支架需求

Intravascular Lithotripsy and the Need for Scaffolding in Isolated Popliteal Lesions.
PubMed 文献 · Ann Vasc Surg · 2026-02-24

该回顾性单中心队列纳入18例孤立性严重钙化腘动脉病变患者,采用血管内碎石术(IVL)预处理,残余狭窄≥30%时植入交织支架,否则使用药物涂层球囊。技术成功率100%,12个月和24个月一期通畅率分别为93%和73%,22%发生主要不良肢体事件,最终56%的患者靶病变接受了支架。

要点

  • IVL对孤立性腘动脉严重钙化病变是有效且安全的血管准备工具。
  • 残余狭窄≥30%时需补救性支架,本队列中39%需要补救性支架。
  • 多数患者最终需支架植入,“不留异物”策略下IVL的获益仍存疑。

核心结论

  • IVL是治疗孤立性腘动脉严重钙化病变的有效且安全的血管准备工具。
  • 由于多数患者最终需要支架植入,在“不留异物”策略下IVL的获益仍存疑。

研究设计与样本

  • IVL后若残余狭窄≥30%则植入交织支架,其他情况使用药物涂层球囊。

主要发现

  • 慢性肢体威胁性缺血占39%,病变长度中位数60 mm(IQR 55-100),慢性完全闭塞占39%,狭窄程度中位数90%(IQR 90-100)。
  • IVL后管腔获得中位数为60%,补救性支架植入占39%,技术成功率100%。
  • 一期通畅率12个月为93%,24个月为73%;随访期间主要不良肢体事件发生率为22%,包括3例再次干预,均发生于未支架植入的患者。
  • 末次随访时56%的患者靶病变接受了支架。

关键数值与推荐

  • IVL后残余狭窄≥30%时植入交织支架,否则使用药物涂层球囊。

临床怎么用

  • 对于孤立性腘动脉严重钙化病变,可考虑使用IVL进行血管准备。
  • 需评估残余狭窄,≥30%时植入支架;应认识到多数患者最终需要支架植入。

局限性

  • 回顾性单中心设计,样本量小(18例),随访时间有限。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: To assess the feasibility, safety, and midterm outcomes of intravascular lithotripsy (IVL) in isolated heavily calcified lesions (HCLs) of the popliteal artery, a location historically regarded as a "no-stent zone". METHODS: This retrospective monocentric cohort included 18 consecutive adult patients where IVL was used to treat a symptomatic isolated popliteal HCL-between November 2021 and September 2025. IVL was followed by interwoven stent implantation in case of residual stenosis ≥30%. In other cases, a drug-coated balloon was used. Technical success, primary and assisted patency, target lesion revascularization, and major adverse limb events (MALE) were recorded. Kaplan-Meier survival analysis was provided for patency and reintervention outcomes. RESULTS: Indication was a chronic limb-threatening ischemia in 39% of the cases. The median lesion length was 60 mm (interquartile range [IQR]: 55-100), and 39% were chronic total occlusions. The median degree of stenosis was 90% (IQR: 90-100). The median luminal gain achieved post-IVL was 60%. Bailout stenting was required in 39% of the cases. The technical success rate was 100%. Primary patency was 93% at 12 months and 73% at 24 months. During follow-up, MALE occurred in 22%, including 3 reinterventions that all occurred in patients treated without stenting. At last follow-up, 56% of the patients had received a stent in the target lesion. CONCLUSION: IVL is an effective and safe vessel preparation tool for isolated popliteal HCLs. Since most patients ultimately require stenting the benefit of IVL in a "nothing left behind" strategy remains questionable.

来源:Ann Vasc Surg,查看原文。版权归原作者所有。

引用

  1. Jacomino V, Mercier L, Dubosq-Lebaz M, et al. Intravascular Lithotripsy and the Need for Scaffolding in Isolated Popliteal Lesions. Ann Vasc Surg. 2026. PMID: 41747929. doi:10.1016/j.avsg.2026.02.018

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。